News Conference News ESC 2012 Prolonged Vorapaxar Enhances Secondary Prevention in Selected Post-MI Patients August 26, 2012
News Conference News ACC 2012 ASCERT: Long-term Survival Advantage with CABG in Multivessel Disease Yael L. Maxwell March 27, 2012
News Conference News ACC 2012 RESOLUTE: Zotarolimus-Eluting Stent Fares Well at 2 Years March 26, 2012
News Conference News ACC 2012 New Antiplatelet Agent Vorapaxar Shows Promise, But At the Expense of Bleeding L.A. McKeown March 24, 2012
News Conference News ACC 2012 ADVANCE: TAVR with CoreValve Safe, Effective at 6 Months March 24, 2012
News Conference News Study Focuses on Permanent Pacemaker Predictors in TAVI vs. Surgery Jason Kahn April 05, 2011
News Conference News PRECOMBAT: PCI with Sirolimus Stent Equivalent to CABG in Left Main Disease April 05, 2011